KWM
ABBV icon

Kaydan Wealth Management’s AbbVie ABBV Stock Holding History

Kaydan Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Buy
1,262
+94
+8% +$20.9K 0.09% 92
2025
Q4 		$267K Buy
1,168
+4
+0.3% +$911 0.08% 94
2025
Q3 		$270K Buy
1,164
+5
+0.4% +$1.02K 0.08% 96
2025
Q2 		$215K Buy
1,159
+4
+0.3% +$743 0.07% 105
2025
Q1 		$242K Buy
1,155
+5
+0.4% +$972 0.08% 96
2024
Q4 		$204K Buy
1,150
+4
+0.3% +$735 0.07% 104
2024
Q3 		$226K Buy
+1,146
New +$214K 0.07% 102
2024
Q2 		– Sell
-1,138
Closed -$207K – 104
2024
Q1 		$207K Buy
+1,138
New +$196K 0.07% 103

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kaydan Wealth Management's ABBV Position: Q1 2026 in Review

Kaydan Wealth Management increased its AbbVie (ABBV) stake by 8% in Q1 2026, buying an estimated $20.9K and bringing the position to 1,262 shares worth $274K. The position accounts for 0.09% of the portfolio, ranked #92.

Kaydan Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 8 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Kaydan Wealth Management held 1,262 shares of AbbVie worth $274K as of Q1 2026.
  • Kaydan Wealth Management bought 94 AbbVie shares in Q1 2026, an estimated $20.9K.
  • AbbVie made up 0.09% of Kaydan Wealth Management's portfolio in Q1 2026, its #92 holding.
  • Kaydan Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 8 quarters since.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Kaydan Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.